Peter C. Verlander
Impact in
- Cancer Research top 10%
- Carcinogens and Genotoxicity Assessment
- Hematology top 10%
Papers in
-
- DNA Repair Mechanisms 11
- CRISPR and Genetic Engineering 3
- Porphyrin Metabolism and Disorders 2
- Genetics 5
- Genomic variations and chromosomal abnormalities 3
- Co-authors
- Arleen D. Auerbach (17 shared papers)Philip F. Giampietro (5 shared papers)Sat Dev Batish (6 shared papers)Jessica G. Davis (4 shared papers)Orna Levran (3 shared papers)John Gregory (2 shared papers)Steven G. Pavlakis (2 shared papers)Barbara Adler‐Brecher (1 shared paper)
- Journals
- Genomics (2 papers)Blood (2 papers)Proceedings of the National Academy of Sciences (2 papers)PEDIATRICS (2 papers)Clinical Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaUnited Kingdom
In The Last Decade
Peter C. Verlander
19 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 70
- Cancer Research 227
- Hematology 132
- Molecular Biology 819
- Genetics 309
- Developmental Biology 21
Countries citing papers authored by Peter C. Verlander
This map shows the geographic impact of Peter C. Verlander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter C. Verlander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter C. Verlander more than expected).
Fields of papers citing papers by Peter C. Verlander
This network shows the impact of papers produced by Peter C. Verlander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter C. Verlander. The network helps show where Peter C. Verlander may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter C. Verlander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2001 | 159 | |
| 2 | 1993 | 147 | |
| 3 | Mutation analysis of the Fanconi anemia gene FACC. | 1994 | 107 |
| 4 | 1997 | 97 | |
| 5 | 1997 | 95 | |
| 6 | 1997 | 94 | |
| 7 | 2001 | 81 | |
| 8 | 2002 | 71 | |
| 9 | 2006 | 65 | |
| 10 | 1995 | 50 | |
| 11 | 1998 | 44 | |
| 12 | 1999 | 35 | |
| 13 | 1995 | 30 | |
| 14 | 1997 | 28 | |
| 15 | A locus for Fanconi anemia on 16q determined by homozygosity mapping. | 1996 | 24 |
| 16 | 1997 | 18 | |
| 17 | 1997 | 9 | |
| 18 | Stem cells in dentistry and medicine: the dentist's role. | 2011 | 5 |
| 19 | 1997 | 3 | |
| 20 | 2005 | 1 |
About Peter C. Verlander
Peter C. Verlander is a scholar working on Molecular Biology, Genetics, Cancer Research, Pulmonary and Respiratory Medicine and Oncology, having authored 20 papers that have together received 1.2k indexed citations. Recurring topics across this work include DNA Repair Mechanisms (11 papers), Genomic variations and chromosomal abnormalities (3 papers), Carcinogens and Genotoxicity Assessment (3 papers), CRISPR and Genetic Engineering (3 papers), Cancer Genomics and Diagnostics (2 papers), Cancer-related Molecular Pathways (2 papers), Porphyrin Metabolism and Disorders (2 papers) and Acute Lymphoblastic Leukemia research (2 papers). The work is most often cited by research in Cancer Research (227 citations), Hematology (132 citations), Molecular Biology (819 citations), Genetics (309 citations) and Developmental Biology (21 citations). Peter C. Verlander has collaborated with scholars based in United States, Australia and United Kingdom. Frequent co-authors include Arleen D. Auerbach, Philip F. Giampietro, Sat Dev Batish, Jessica G. Davis, Orna Levran, John Gregory, Steven G. Pavlakis, Barbara Adler‐Brecher, Alfred P. Gillio and Christopher G. Mathew. Their work appears in journals such as Genomics, Blood, Proceedings of the National Academy of Sciences, PEDIATRICS and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.